High Purity Melanotan II Mt2 CAS 121062-08-6 for Skin Tanning
TDS 12 Inquiries
112603-35-7
Pharmaceutical Grade
99%
guangdong
CaoQuan
10mg/vial; 10vials/box
2025-08-30
Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
insulin-like growth factor 1, des-(1-3)-
Other Name:insulin-like growth factor 1, des-(1-3)-;4-70-Insulin-likegrowth factor I (huMan);Insulin-lkie Growth Factor(IGF-1);IGF-1 DES 1mg/2mg
CAS No.:112603-35-7
Molecular Weight:0
Categories:
Research-
Class:
Synthetic cyclic heptapeptide / non-selective melanocortin receptor agonist
Status:Research compound — NOT FDA approved. FDA issued warning letters. WADA banned substance.
Mechanism:A synthetic cyclic heptapeptide (Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂) analog of α-MSH. Melanotan II is a high-affinity non-selective agonist at MC1R, MC3R, MC4R, and MC5R. MC1R activation induces melanogenesis (skin darkening/tanning); MC4R activation affects sexual function, appetite suppression, and energy homeostasis. Carries significant safety risks including nausea, hypertension, and priapism.
EC50 (Human Mc1r Ki):1.2 nM
EC50 (Human Mc5r Ki):1.0 nM
EC50 (Human Mc3r Ki):1.1 nM
EC50 (Human Mc4r Ki):2.1 nM
Source:Wikberg JES, et al. Pharmacol Res. 2000;42(5):393–420. PubChem CID 92432.DOI
Clinical Development:
References-
ChEMBL:
CHEMBL363210
PubChem:Literature:FDA Warning Letters: Melanotan II (unapproved drug); WADA Prohibited List: Melanotan II (S2 hormone modulator)
Disclaimer:Melanotan II is NOT FDA-approved. The FDA has issued multiple warning letters to companies illegally selling Melanotan II as an unapproved new drug. It is also listed on the WADA Prohibited List as a banned substance in sport. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Cagrilintide,Tirzepatide,Semaglutide,Retatrutide,NAD+,Melatonine
-
Location:
Room 102, No. 60-20, Gongnong Street, Xiangya Road Subdistrict, Kaifu District, Changsha City, Hunan Province, China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2023
-
Certifications:
certificate
-
-
Inquiry History12 Inquiries
Country Product Purchase Quantity Date Posted
China
TSM
1000 Jun 15, 2026
China
Igf-1 DES
50 MG Dec 15, 2025
Russia
igf-1 des 1-3
1 G Apr 22, 2025
Australia
IGF-1 DES
1 MT Feb 28, 2026
France
IGF1 DES
30 MG Jan 27, 2026
United States
Igf-1 DES
1 MT Nov 19, 2025
United States
IGF-1 DES
1 G Oct 11, 2024
United States
IGF1 DES
10 MG Jul 31, 2026
Cyprus
Igf-1 des
150 MG Jul 9, 2026
Netherlands
IGF-1 DES
1200 MG Jun 27, 2026
United States
IGF-DES
20 MG Apr 10, 2026
United States
High Quality IGF-1 DES Peptide Manufacturer 99% Pure
2 MG Oct 9, 2025 Post an enquiry for this product
